Embecta Share Price (NASDAQ: EMBC)

$14.46

▲

-0.04

(-0.28%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Embecta Stock chart to analyse performance

Embecta stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$14.46
Today's High:$14.62
$14.46
0.03%
Downside
Day's Volatility :1.13%
Upside
1.09%
52 Weeks Low:$9.20
52 Weeks High:$21.48
$14.46
36.38%
Downside
52 Weeks Volatility :57.17%
Upside
32.68%

Embecta Stock Returns

Period	Embecta Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	38.47%	3.6%	0.0%
6 Months	12.43%	-7.7%	0.0%
1 Year	-12.09%	-12.6%	0.0%
3 Years	-54.77%	9.5%	-4.7%

Embecta Corp Key Stats

Check Embecta key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$14.5
Open	$14.56
Today's High	$14.62
Today's Low	$14.455
Market Capitalization	$853.3M
Today's Volume	$366.8K
52 Week High	$21.48
52 Week Low	$9.2
Revenue TTM	$1.1B
EBITDA	$110.9M
Earnings Per Share (EPS)	$1.42
PE Ratio	10.21
Dividend Yield	4.11%
Profit Margin	7.58%
Quarterly Earnings Growth YOY	2.11%
Return On Equity TTM	0.0%

Stock Returns calculator for Embecta Stock including INR - Dollar returns

The Embecta stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Embecta investment value today

Current value as on today

₹93,779

Returns

₹6,221

(-6.22%)

Returns from Embecta Stock

₹11,506 (-11.51%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Embecta Stock

60%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Embecta Stock from India on INDmoney has increased by 60% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Embecta Corp

Name
Holdings %
Name
Holdings %
BlackRock Inc
15.65%
Vanguard Group Inc
9.35%
American Century Companies Inc
8.89%
River Road Asset Management, LLC
5.52%
Deerfield Management Co
4.70%
State Street Corp
4.08%

Analyst Recommendation on Embecta Stock

Rating

Trend

Sell

0%Buy

44%Hold

55%Sell

Based on 9 Wall street analysts offering stock ratings for Embecta(by analysts ranked 0 to 5 stars)

Embecta Share Price Target

What analysts predicted

Upside of 15.26%

Target:

$16.67

Current:

$14.46

Embecta share price target is $16.67, a slight Upside of 15.26% compared to current price of $14.46 as per analysts' prediction.

Embecta Stock Insights

Price Movement
In the last 1 month, EMBC stock has moved up by 38.5%
Increasing Revenue
Revenue is up for the last 2 quarters, 259.0M → 295.5M (in $), with an average increase of 12.4% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -700.0K → 45.5M (in $), with an average increase of 75.7% per quarter
EMBC vs RMD (1 yr)
In the last 1 year, Resmed Inc. has given 12.2% return, outperforming this stock by 23.6%
EMBC vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 25.2% return, outperforming this stock by 78.9%
Price to Sales
ForEMBC every $1 of sales, investors are willing to pay $0.8, whereas for Resmed Inc., the investors are paying $7.8 for every $1 of sales.

Embecta Corp Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$1.1B	-
Net Income	$432.0M	-
Net Profit Margin	38.95%	-

	FY20	Y/Y Change
Revenue	$1.1B	↓ 2.12%
Net Income	$427.6M	↓ 1.02%
Net Profit Margin	39.39%	↑ 0.44%

	FY21	Y/Y Change
Revenue	$1.2B	↑ 7.32%
Net Income	$414.8M	↓ 2.99%
Net Profit Margin	35.61%	↓ 3.78%

	FY22	Y/Y Change
Revenue	$1.1B	↓ 3.05%
Net Income	$223.6M	↓ 46.09%
Net Profit Margin	19.8%	↓ 15.81%

	FY23	Y/Y Change
Revenue	$1.1B	↓ 0.77%
Net Income	$70.4M	↓ 68.52%
Net Profit Margin	6.28%	↓ 13.52%

	FY24	Y/Y Change
Revenue	$1.1B	↑ 0.21%
Net Income	$78.3M	↑ 11.22%
Net Profit Margin	6.97%	↑ 0.69%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$287.2M	↑ 3.57%
Net Income	$28.9M	↑ 43.78%
Net Profit Margin	10.06%	↑ 2.81%

	Q2 FY24	Q/Q Change
Revenue	$272.5M	↓ 5.12%
Net Income	$14.7M	↓ 49.13%
Net Profit Margin	5.39%	↓ 4.67%

	Q3 FY24	Q/Q Change
Revenue	$286.1M	↑ 4.99%
Net Income	$14.6M	↓ 0.68%
Net Profit Margin	5.1%	↓ 0.29%

	Q4 FY24	Q/Q Change
Revenue	$261.9M	↓ 8.46%
Net Income	$-700.0K	↓ 104.79%
Net Profit Margin	-0.27%	↓ 5.37%

	Q1 FY25	Q/Q Change
Revenue	$259.0M	↓ 1.11%
Net Income	$23.5M	↓ 3457.14%
Net Profit Margin	9.07%	↑ 9.34%

	Q2 FY25	Q/Q Change
Revenue	$295.5M	↑ 14.09%
Net Income	$45.5M	↑ 93.62%
Net Profit Margin	15.4%	↑ 6.33%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$786.0M	-

	FY20	Y/Y Change
Profit	$762.6M	↓ 2.98%

	FY21	Y/Y Change
Profit	$800.0M	↑ 4.9%

	FY22	Y/Y Change
Profit	$774.9M	↓ 3.14%

	FY23	Y/Y Change
Profit	$749.9M	↓ 3.23%

	FY24	Y/Y Change
Profit	$735.2M	↓ 1.96%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$184.2M	↓ 0.91%

	Q2 FY24	Q/Q Change
Profit	$190.1M	↑ 3.2%

	Q3 FY24	Q/Q Change
Profit	$173.8M	↓ 8.57%

	Q4 FY24	Q/Q Change
Profit	$157.1M	↓ 9.61%

	Q1 FY25	Q/Q Change
Profit	$164.1M	↑ 4.46%

	Q2 FY25	Q/Q Change
Profit	$197.1M	↑ 20.11%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$505.0M	-
Investing Cash Flow	$-69.0M	-
Financing Cash Flow	$-436.0M	-

	FY20	Y/Y Change
Operating Cash Flow	$498.5M	↓ 1.29%
Investing Cash Flow	$-41.9M	↓ 39.28%
Financing Cash Flow	$-456.6M	↑ 4.72%

	FY21	Y/Y Change
Operating Cash Flow	$456.0M	↓ 8.53%
Investing Cash Flow	$-39.0M	↓ 6.92%
Financing Cash Flow	$-417.0M	↓ 8.67%

	FY22	Y/Y Change
Operating Cash Flow	$412.2M	↓ 9.61%
Investing Cash Flow	$-24.0M	↓ 38.46%
Financing Cash Flow	$-48.0M	↓ 88.49%

	FY23	Y/Y Change
Operating Cash Flow	$67.7M	↓ 83.58%
Investing Cash Flow	$-26.5M	↑ 10.42%
Financing Cash Flow	$-48.7M	↑ 1.46%

	FY24	Y/Y Change
Operating Cash Flow	$35.7M	↓ 47.27%
Investing Cash Flow	$-15.8M	↓ 40.38%
Financing Cash Flow	$-73.4M	↑ 50.72%

Q1 FY24

Q2 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$24.3M	↓ 285.5%
Investing Cash Flow	$-3.4M	↑ 25.93%
Financing Cash Flow	$-11.8M	↓ 12.59%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-2.1M	↓ 108.64%
Investing Cash Flow	$-9.7M	↑ 185.29%
Financing Cash Flow	$-11.5M	↓ 2.54%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-5.3M	↓ 119.92%
Investing Cash Flow	$-1.5M	-
Financing Cash Flow	$-45.2M	↑ 23.5%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$31.8M	↓ 700.0%
Investing Cash Flow	$-100.0K	↓ 93.33%
Financing Cash Flow	$-37.3M	↓ 17.48%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$81.2M	↑ 155.35%
Investing Cash Flow	$-400.0K	↑ 300.0%
Financing Cash Flow	$-62.6M	↑ 67.83%

Embecta Technicals Summary

Sell

Neutral

Buy

Embecta is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Embecta Corp Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Embecta Corp	45.28%	12.43%	-12.09%	-54.77%	-51.73%
Intuitive Surgical, Inc.	-2.14%	-16.61%	-2.2%	129.39%	91.27%
Alcon Ag	-9.17%	-15.22%	-16.6%	20.12%	40.07%
West Pharmaceutical Services Inc	3.24%	8.32%	-18.78%	-16.58%	-12.33%
Resmed Inc.	-1.56%	17.91%	12.23%	25.22%	53.62%
Becton, Dickinson And Company	9.36%	-15.57%	-20.36%	-24.43%	-19.91%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Embecta Corp	10.21	10.21	NA	2.93	0.0	0.04	0.04	-11.45
Intuitive Surgical, Inc.	66.27	66.27	3.47	8.14	0.16	0.09	NA	49.79
Alcon Ag	36.78	36.78	2.16	3.1	0.05	0.03	0.0	44.73
West Pharmaceutical Services Inc	36.74	36.74	3.55	6.76	0.18	0.11	0.0	40.74
Resmed Inc.	28.99	28.99	1.9	9.5	0.26	0.14	0.01	40.77
Becton, Dickinson And Company	35.34	35.34	0.96	14.37	0.06	0.04	0.02	88.87

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Embecta Corp	Sell	$853.3M	-51.73%	10.21	7.58%
Intuitive Surgical, Inc.	Buy	$169.9B	91.27%	66.27	28.51%
Alcon Ag	Buy	$39.3B	40.07%	36.78	10.7%
West Pharmaceutical Services Inc	Buy	$17.7B	-12.33%	36.74	16.48%
Resmed Inc.	Buy	$40.3B	53.62%	28.99	27.22%
Becton, Dickinson And Company	Buy	$55.3B	-19.91%	35.34	7.41%

About Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Organization	Embecta
Employees	2100
CEO	Mr. Devdatt Kurdikar Ph.D.
Industry	Healthcare

Key Management of Embecta Corp

Name	Title
Mr. Devdatt Kurdikar Ph.D.	President, CEO & Director
Mr. Jacob P. Elguicze	Senior VP & CFO
Mr. Jeffrey Z. Mann	Senior VP, General Counsel, Head of Business Development & Corporate Secretary
Ms. Jean M. Casner	Senior VP & Chief Human Resources Officer
Mr. Shaun Curtis	Senior Vice President of Global Manufacturing & Supply Chain
Mr. Anthony M. Roth	VP, Chief Accounting Officer & Corporate Controller
Ms. Colleen Riley	Senior VP & Chief Technology Officer
Mr. Pravesh Khandelwal	VP & Head of Investor Relations
Ms. Ginny Blocki	Senior Vice President of Global Marketing & Product Management
Mr. Tom Blount	Senior VP & President of North America

Important FAQs about investing in EMBC Stock from India :

What is Embecta share price today?

Embecta share price today is $14.46 as on August 30, 2025 at 1:29 am IST at the close of the market. Embecta share today touched a day high of $14.62 and a low of $14.46.

What is the 52 week high and 52 week low for Embecta share?

Embecta share touched a 52 week high of $21.48 and a 52 week low of $9.20. Embecta stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $14.46, lower by 32.68% versus the 52 week high.

How to invest in Embecta Stock (EMBC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Embecta on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Embecta Shares that will get you 0.1037 shares as per Embecta share price of $14.46 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Embecta Stock (EMBC) from India?

Indian investors can start investing in Embecta (EMBC) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Embecta stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Embecta share’s latest price of $14.46 as on August 30, 2025 at 1:29 am IST, you will get 0.6916 shares of Embecta. Learn more about fractional shares .

What are the returns that Embecta has given to Indian investors in the last 5 years?

Embecta stock has given -51.73% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?